Pharma Focus Asia
Klöckner Pentaplast - Pentapharm® alfoil® films

Jaguar Gene Therapy Plans US$125 million Investment

Introduction:

Jaguar Gene Therapy plans to open new commericial manufacturing facility in North Carolina. It expands stargegic capabilities from process development through commercial GMP production.

Features:

The new state-of-the-art gene therapy facility will be constructed in 174,000-square-foot and will be located approximately 20 miles from Jaguar’s existing Process. It is designed to produce various gene therapies for severe genetic diseases.

The new facility will make use of advance technologies and purification techniques to increase product yields while reducing product impurities. In addition, the facility provides to have a greater control of the manufacturing process and ensures highest purity level of products.

After the completion of the new facility, it is expected to create 200 jobs in the next several years.

This new investment quickens development timelines and bring out therapies safely and in faster manner to patients and families.

Specifications:

NameJaguar Gene Therapy
TypeNew Construction
BudgetUS$125 million
magazine-slider-imageBIOVIA from Molecule to MedicineMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024